Grace Halsey

VIDEO Interview: The COVID-19 pandemic has closed what discussion remained about the status of obesity as a disease, according to obesity expert Donna Ryan, MD.

WATCH: The FDA approval of semaglutide 2.4 mg for adults with obesity was "by far the big event in 2021," said Donna Ryan, MD. More from our look back/look ahead interview, here.

Using Mendelian randomization, a new study found in particular that waist-hip ratio may be a more important predictor of hospitalization than BMI.

Screening of older adults for falls and cognitive impairment should be routine in primary care; a recent study highlights an intervention that could help.

Seven at-home COVID-19 rapid tests, all available online or at retail, are ranked for dexterity required, instruction legibility, and other features you may need to parse for your patients.

The largest US non-profit patient safety organization evaluated 7 COVID-19 rapid tests and found serious deficiencies in usability; none were rated "excellent."

Click through top flu indicators tracked by the Centers for Disease Control and Prevention weekly US influenza surveillance report.

Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.

Digital health products and advanced remote monitoring applications received more attention than ever at CES, driven by rapid evolution in the space during the COVID-19 pandemic.

"COVID-somnia," defined as a group of chronic sleep disturbances, has made adequate rest elusive for millions, including health care first responders.

The ADA's annual update to its comprehensive evidence-based standards includes new guidance on diabetes screening, first-line therapies, and comorbid NAFLD/NASH.

The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.

The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.

While use of insulin pumps and CGM increased over a 3-year study period for all racial-ethnic groups, the inequities were significant between White adults and all others.

Finerenone, the nonsteroidal mineralocorticoid receptor antagonist, significantly reduced new-onset HF and improved other HF outcomes in the FIGARO-DKD trial.

Pfizer reported today final results of the phase 2/3 EPIC-HR trial, findings that confirm the investigational drug's 89% efficacy against severe COVID-19 disease.

Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.

Increases in obesity parameters significantly increased risk of incident heart failure in persons with diabetes, but not without diabetes, in a large community-based cohort study.

Intranasal CGRP inhibitor zavegepant met coprimary regulatory endpoints in pivotal phase 3 trial in adults with migraine; FDA submission planned for Q1 2022.

The annual "America's Health Rankings" report found Louisiana ranked lowest in 3 of the 5 categories assessed. Find the 5 states ranking highest and lowest in each for 2021.

A digital text highlighter/scanner that translates and talks back; those stethoscopes with the wild-animal themed tubing. Check them out, plus 8 more Great Doctor Gifts.

The Guideline Toplines slide-show feature offers busy primary care physicians at-a-glance summaries of new and updated clinical guidelines across therapeutic areas.

Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?

A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.

Daily e-cigarette use was associated with more than twice the odds of reporting erectile dysfunction vs never using e-cigarettes, independent of other common ED risk factors.

Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.

The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.

In an effort to support some good-natured holiday healthcare gift-giving, editors at Patient Care® did some window shopping for you. Take a moment, take a breath, and scroll.

Find out how effective each of 8 ACC/AHA-recommended non-drug interventions is at reducing BP (in mm Hg) in adults with hypertension and normal BP.

The Omicron variant of COVID-19 was today identified for the first time in the US, according to the CDC. Get a topline look at other recent breaking news in this slide show.